Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
Clinical trial NCT00407459 · COMPLETED
Trial details
- NCT number
- NCT00407459
- Sponsor
- Armando Santoro, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-11-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.